Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 30, 2017	Dec. 31, 2016
Cash Flows from Operating Activities:
Net Earnings	$ 439	$ 15,575
Adjustments to Reconcile Net Earnings to Net Cash Used In Operations (Net of Acquisition):
Depreciation & Amortization	23,112	18,209
(Gain) Loss on the Sale of Assets	(1,590)	149
Bargain purchase gain	(1,078)
Provision for Restructuring and Impairment	157	3,830
Earnings From Equity Investment	(21)	(500)
Deferred Income Tax Benefit	16	(1,705)
Changes in Operating Assets and Liabilities:
Accounts Receivable	11,891	9,431
Inventories	(125,691)	(89,964)
Other Current Assets	954	4,619
Income Taxes	240	5,856
Accounts Payable, Deferred Revenue, Accrued Expenses and Other Liabilities	64,823	24,791
Net Cash Used in Operations	(26,748)	(9,709)
Cash Flows from Investing Activities:
Additions to Property, Plant and Equipment	(21,120)	(23,389)
Cash Paid for Acquisition (Net of Cash Acquired)	(14,420)
Proceeds from the Sale of Assets	1,841	123
Net Cash Used In Investing Activities	(33,699)	(23,266)
Cash Flow from Financing Activities:
Long-Term Borrowing	438,730	411,483
Payments on Long-Term Debt and Capital Lease Obligations	(373,298)	(374,577)
(Payments) Borrowings on Notes Payable	(166)	853
Other Assets	(235)	(1,273)
Purchase of Treasury Stock	(3,442)	(1,841)
Dividends	(12)	(12)
Net Cash Provided by Financing Activities	61,577	34,633
Net Increase in Cash and Cash Equivalents	1,130	1,658
Cash and Cash Equivalents, Beginning of the Period	11,992	8,602
Cash and Cash Equivalents, End of the Period	13,122	10,260
Noncash Transactions:
Property, Plant and Equipment Purchased Under Capital Lease Obligations	8,381	23,056
Silgan Payable	$ 8,000